feed,title,long_url,short_url
SeekingAlpha,FDA clears DexCom's glucose monitoring system for all diabetes types aged 2 or older,https://seekingalpha.com/news/3915296,
SeekingAlpha,Design slumps 30% amid phase 1 data of DT-216 for neurodegenerative disorder,https://seekingalpha.com/news/3915295,
